Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ø Torkildsen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
European Journal of Neurology|August 23, 2018
Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'S Wergeland, T Riise, Ø Torkildsen
Acta Neurologica Scandinavica. Supplementum|April 11, 2007
Immunomodulatory treatment of multiple sclerosis in NorwayØ Torkildsen, N Grytten, K-M Myhr
European Journal of Neurology|November 14, 2015
Disease-modifying treatments for multiple sclerosis - a review of approved medicationsØ Torkildsen, K-M Myhr, L Bø
Acta Neurologica Scandinavica|June 6, 2015
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decadesN Grytten, Ø Torkildsen, K-M Myhr
Acta Neurologica Scandinavica|September 16, 2015
Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'N Grytten, Ø Torkildsen, K M Myhr
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Polyunsaturated fatty acids in multiple sclerosis therapyS Wergeland, Ø Torkildsen, L Bø, et al.
European Journal of Neurology|November 29, 2007
Epstein-Barr virus reactivation and multiple sclerosisØ Torkildsen, H Nyland, H Myrmel, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and whereforeT Holmøy, Ø Torkildsen, K-M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum|November 30, 2012
Fat-soluble vitamins as disease modulators in multiple sclerosisØ Torkildsen, K I Løken-Amsrud, S Wergeland, et al.
Acta Neurologica Scandinavica|June 6, 2015
The Norwegian Multiple Sclerosis Registry and BiobankK-M Myhr, N Grytten, Ø Torkildsen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Journal of Neurology|August 23, 2018
Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'S Wergeland, T Riise, Ø Torkildsen
Acta Neurologica Scandinavica. Supplementum|April 11, 2007
Immunomodulatory treatment of multiple sclerosis in NorwayØ Torkildsen, N Grytten, K-M Myhr
European Journal of Neurology|November 14, 2015
Disease-modifying treatments for multiple sclerosis - a review of approved medicationsØ Torkildsen, K-M Myhr, L Bø
Acta Neurologica Scandinavica|June 6, 2015
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decadesN Grytten, Ø Torkildsen, K-M Myhr
Acta Neurologica Scandinavica|September 16, 2015
Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'N Grytten, Ø Torkildsen, K M Myhr
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Polyunsaturated fatty acids in multiple sclerosis therapyS Wergeland, Ø Torkildsen, L Bø, et al.
European Journal of Neurology|November 29, 2007
Epstein-Barr virus reactivation and multiple sclerosisØ Torkildsen, H Nyland, H Myrmel, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and whereforeT Holmøy, Ø Torkildsen, K-M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum|November 30, 2012
Fat-soluble vitamins as disease modulators in multiple sclerosisØ Torkildsen, K I Løken-Amsrud, S Wergeland, et al.
Acta Neurologica Scandinavica|June 6, 2015
The Norwegian Multiple Sclerosis Registry and BiobankK-M Myhr, N Grytten, Ø Torkildsen, et al.
Pageof 2